Elias Arbid, MD
Vascular Surgery · Rock Hill, SCNPI 1578561528
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (40.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 66.9% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2022 at $9,963 and has fallen 97.6% since, to $239 in 2025.
Across 198 payments — averaging $93.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$12K
- Johnson & Johnson$2K
- Endologix LLC$624
- Philips North America LLC$569
- Boston Scientific$415
- Medtronic$405
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,57535%
- Education$4,50024%
- Other$7,50040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 6 | $12,435 |
| Johnson & Johnson(2 entities) | 111 | $1,738 |
| Endologix LLC | 4 | $624 |
| Philips North America LLC | 6 | $569 |
| Boston Scientific | 11 | $415 |
| Medtronic(2 entities) | 7 | $405 |
| Organogenesis Inc. | 2 | $353 |
| Bard Peripheral Vascular, Inc. | 4 | $346 |
| Cook Medical LLC | 3 | $252 |
| Tactile Systems Technology Inc | 7 | $168 |
| Shockwave Medical, Inc | 2 | $152 |
| Abbott | 5 | $117 |
| Getinge USA Sales, LLC | 1 | $107 |
| Stability Biologics, LLC | 1 | $105 |
| Cardiva Medical, Inc. | 4 | $90 |
| Veryan Medical Incorporated | 1 | $89 |
| Molnlycke Health Care US, LLC | 1 | $84 |
| Silk Road Medical, Inc. | 2 | $80 |
| Smith+Nephew | 4 | $78 |
| Novo Nordisk | 1 | $61 |
| Venclose Inc. | 1 | $52 |
| Biocompatibles, Inc. | 2 | $47 |
| Cardiovascular Systems Inc. | 2 | $31 |
| Lemaitre Vascular, Inc. | 2 | $27 |
| Cvrx, Inc. | 1 | $25 |
| Triad Life Sciences Inc. | 1 | $23 |
| Artivion, Inc. | 1 | $22 |
| Misonix Inc | 1 | $22 |
| Inari Medical, Inc. | 1 | $19 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Baudax Bio Inc. | 1 | $14 |
| Biom'up France SAS | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$12,000
- AFX2 Bifurcated Endograft System$624
- Ovation iX Iliac Stent Graft$624
- Turbo Elite$357
- PuraPly$353
- XARELTO$236
- Valiant Captivia$182
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$139
- ROSEN$138
- RotarexS 6 F x 135 cm$126
- HawkOne$124
- (6582) Visions 035$124
- Venclose Maven Catheter$120
- Peripheral RotaLink Plus$114
- iCAST$107
How this compares
$18,575 in reported general payments places this provider in the 80th percentile of 99 vascular surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $52,780 |
| XareltoRivaroxaban | 44 | $48,251 |
| ClopidogrelClopidogrel Bisulfate | 86 | $684 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 63 | $517 |
| Rosuvastatin Calcium | 30 | $453 |
| Cilostazol | 21 | $385 |
| Gabapentin | 19 | $319 |
| Atorvastatin Calcium | 20 | $216 |
| Metoprolol Succinate | 16 | $209 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 11 | $160 |
| Amlodipine Besylate | 31 | $97 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $81 |
| Metoprolol Tartrate | 14 | $69 |
| Spironolactone | 16 | $50 |
| Carvedilol | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $1,738 | $48,25144 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 99 vascular surgery providers in South Carolina.
Other vascular surgery in Rock Hill
- Daniel McDevittRock Hill$52K
- Patrick DuffyRock Hill$12K
- Emilia KrolRock Hill$10K
- Michael NaylorRock Hill$7K
- John RossOrangeburg$847K
- David DeatonColumbia$609K
- Mathew WoosterWest Columbia$443K
- Sagar GandhiGreenville$236K
- Ravi VeeraswamyCharleston$164K
- Gerald FortunaWest Columbia$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.